Phibro Animal Health Corporation (PAHC)

NASDAQ: PAHC · USD

$38.0

-0.41 (-1.1%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	1.5B
Net income (ttm)	99.7M
EPS (ttm)	$2.43
Shares out	40.6M
P/E (trailing)	15.6x
P/E (forward)	10.9x
Dividend	$0.48 (1.26%)
Volume	122,502
Beta	0.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 99.7M
EPS (ttm): $2.43
P/E (trailing): 15.6x
P/E (forward): 10.9x
Market cap: 1.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.9

P25 n/aP50 n/aP75 n/a

Trailing P/E15.6

P25 n/aP50 n/aP75 n/a

ROE29.7

P25 n/aP50 n/aP75 n/a

ROIC13

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PAHC indicators

Market & fundamental data

Available fields

283

Groups with data

Currency

USD

Showing 283 of 283 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001069899
Company name	Phibro Animal Health Corporation
Country	United States
Country code	US
CUSIP number	71742Q106
Earnings date	2026-11-09
Earnings time	amc
Employees	2,605
Employees change	130
Employees growth	5.25%
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	1946
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2014-04-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US71742Q1067
Last 10-K release date	2026-08-26
Last earnings date	2026-08-26
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$37.97
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PAHC
U.S. state	New Jersey
Website	https://www.pahc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	11.83x
Average P/E ratio (10Y)	29.32x
Average P/E ratio (3Y)	49.97x
Average P/E ratio (5Y)	36.39x
Earnings yield	6.4%
EV/Earnings	22.7x
EV/EBIT	11.65x
EV/EBITDA	9.27x
EV/FCF	229.46x
EV/Sales	1.49x
FCF / EV yield	0.44%
FCF yield	0.64%
Forward EV/Sales	1.43x
Forward P/E	10.91x
Forward P/S	0.98x
Graham number	22.79394
Graham upside	-40.38%
Industry forward P/E	13.87x
Industry P/E	173.94x
Lynch fair value	$31.33
Lynch upside	-18.06%
P/(FCF - SBC) ratio	187.71x
P/(OCF - SBC) ratio	23.04x
P/B ratio	4.04x
P/E ratio	15.63x
P/FCF ratio	157.33x
P/OCF ratio	22.51x
P/S ratio	1.02x
Price / tangible book value	5.25x
Price/EBITDA ratio	6.36x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.8%
EBITDA margin	16.09%
Effective tax rate	27.4%
FCF margin	0.65%
Gross margin	33.33%
Operating margin	12.8%
Pretax margin	9.05%
Profit margin	6.57%
Profit per employee	$38,280
Profitable quarters	11
Profitable years	12
Revenue per employee	$582,761
ROA	8.48%
ROA (5Y)	5.99%
ROCE	16.39%
ROE	29.72%
ROE (5Y)	16%
ROIC	13%
ROIC (5Y)	8.57%
SBC / revenue	0.11%
Tax / revenue	2.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	104.2%
EPS growth (Q)	24.6%
EPS growth (QoQ)	-10.19%
EPS growth 10Y	1.62%
EPS growth 3Y	44.52%
EPS growth 5Y	12.64%
EPS growth quarters	8
EPS growth years	2
FCF growth	-76.42%
FCF growth (Q)	-35.73%
FCF growth (QoQ)	487.08%
FCF growth 5Y	-12.27%
Gross profit growth	23.58%
Gross profit growth (Q)	12.06%
Gross profit growth 3Y	19.27%
Gross profit growth 5Y	13.27%
Net income growth	106.61%
Net income growth (Q)	26.05%
Net income growth (QoQ)	-9.63%
Net income growth 3Y	45.15%
Net income growth 5Y	12.89%
Net income growth quarters	8
Net income growth years	2
OCF growth	-13.94%
OCF growth (Q)	13.27%
OCF growth (QoQ)	48.67%
OCF growth 10Y	6.36%
OCF growth 3Y	73.03%
OCF growth 5Y	7.38%
Operating income growth	39.85%
Operating income growth (Q)	8.53%
Operating income growth 3Y	39.31%
Operating income growth 5Y	21.01%
Revenue growth	17.12%
Revenue growth (Q)	4.77%
Revenue growth (QoQ)	3.44%
Revenue growth 10Y	7.28%
Revenue growth 3Y	15.79%
Revenue growth 5Y	12.74%
Revenue growth quarters	11
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-59.1M
Depreciation and amortization	$50M
EBIT	$194.2M
EBITDA	$244.2M
EPS	$2.43
FCF per share	$0.24
Financing cash flow	$-6.6M
Free cash flow	$9.9M
Free cash flow minus SBC	$8.3M
Gross profit	$506M
Income taxes	$37.6M
Investing cash flow	$-71.5M
Net borrowing	$13.5M
Net cash flow	$-6.6M
Net income	$99.7M
Operating cash flow minus SBC	$67.4M
Operating income	$194.2M
Revenue	$1.5B
Stock-based compensation	$1.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.15
Book value per share	$9.50
Debt / EBITDA	3.06
Debt / equity	2.06
Debt / FCF	80.65
Goodwill	$60M
Interest coverage	4.18
Long-term assets	$565.7M
Long-term liabilities	$799.3M
Net cash (debt)	$-711.7M
Net cash / market cap	-45.85%
Net debt / EBITDA	2.91
Net debt / equity	1.85
Net debt / FCF	72.13
Piotroski F-Score	5
Property, plant and equipment	$420.7M
Shareholders' equity	$385.5M
Tangible book value	$295.4M
Tangible book value per share	$7.28
Total assets	$1.5B
Total cash	$84M
Total debt	$795.6M
Total liabilities	$1.1B
WACC	5.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.06
Current assets	$935.5M
Current liabilities	$316.5M
Current ratio	2.96
Inventory turnover	2.07
Net working capital	$577.5M
Quick ratio	1.02
Working capital	$619M
Working capital turnover	2.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.7%
Dividend growth	0%
Dividend growth (10Y)	1.84%
Dividend growth (3Y)	0%
Dividend growth (5Y)	0%
Dividend growth years	0
Dividend payment date	2026-09-23
Dividend payment years	13
Dividend payout frequency	Quarterly
Dividend per share	$0.48
Dividend yield	1.26%
Ex-dividend date	2026-09-02
FCF payout ratio	197.53%
Last dividend	$0.12
Payout ratio	19.75%
Shareholder yield	0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	48.23%
10Y return CAGR	6.18%
10Y total return	82.13%
150-day SMA	$38.96
1D price change	-1.07%
1M price change	10.8%
1M total return	10.8%
1W price change	-1.62%
1W total return	-1.62%
1Y price change	-8.47%
1Y return CAGR	-7.33%
1Y total return	-7.33%
20-day SMA	$38.04
200-day SMA	$41.28
3M price change	8.31%
3M total return	8.65%
3Y price change	254.41%
3Y return CAGR	55.75%
3Y total return	277.91%
50-day SMA	$36.86
50-day SMA vs 200-day SMA	50under200
52-week high	$60.08
52-week high date	2026-04-13
52-week low	$28.25
52-week low date	2026-06-02
5Y price change	73.97%
5Y return CAGR	14.53%
5Y total return	97.06%
6M price change	-32.01%
6M total return	-31.51%
All-time high	$60.08
All-time high date	2026-04-13
All-time low	$9.40
All-time low date	2023-11-13
Average true range (ATR)	$1.31
Average volume	203.4K
Beta (1Y)	-0.52
Beta (2Y)	0.57
Beta (5Y)	0.42
Change from 52-week high	-36.8%
Change from 52-week low	34.41%
Change from all-time high	-36.47%
Change from all-time low	306.06%
Change from open	-0.65%
Day's gap	-0.42%
Dollar volume	$4.7M
High price	$38.22
Low price	$37.91
Monthly RSI	54.78
Open price	$38.22
Position in 52-week range	19.35%
Premarket change	-1.98%
Premarket close	$38.38
Premarket price	$37.62
Previous close	$38.38
Price vs 150-day SMA	-2.03%
Price vs 20-day SMA	0.33%
Price vs 200-day SMA	-7.53%
Price vs 50-day SMA	3.57%
Relative volume	0.6
RSI	53.18
Sharpe ratio	0.06
Sharpe ratio (3Y)	0.99
Sharpe ratio (5Y)	0.43
Sortino ratio	0.19
Sortino ratio (3Y)	1.72
Sortino ratio (5Y)	0.8
Volume	122.5K
Weekly RSI	50.59
YTD price change	2.17%
YTD total return	3.16%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20.9M
Float percentage	51.5%
Shares change (QoQ)	-0.09%
Shares change (YoY)	0.7%
Shares held by insiders	48.47%
Shares held by institutions	54.08%
Shares outstanding	40.6M
Short % of float	4.88%
Short % of shares	2.51%
Short ratio	4.1 days

Deeper analysis on PAHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PAHC report

Is a complete PAHC research report available?

No complete published report is available for Phibro Animal Health Corporation (PAHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Phibro Animal Health Corporation (PAHC)

Price

Financial snapshot

Fair-value bridge

Latest news · PAHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PAHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PAHC

Frequently asked questions